Cipla Files ANDA For Advair Rival

FDA Will Now Consider Indian Firm’s Version Alongside Hikma

 
• By David Wallace
  
Fresh_Air
Cipla’s ANDA is being considered alongside Hikma’s filing • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products